ASSESSING BASELINE MEDICATION USE IN CHRONIC KIDNEY DISEASE: AN ANALYSIS OF THE SHARP-ER STUDY

被引：0
|
作者：
Jun, M. [1 ]
Sukkar, L. [1 ,2 ]
Jardine, M. [1 ]
Talbot, B. [1 ]
Cass, A. [3 ]
Reith, C. [4 ,5 ]
Walker, R. [6 ]
Gallagher, M. [1 ,2 ]
机构：
[1] George Inst Global Hlth, Newtown, Tas, Australia
[2] Univ Sydney, Sydney Sch Publ Hlth, Camperdown, NSW, Australia
[3] Menzies Sch Hlth Res, Darwin, NT, Australia
[4] Univ Oxford, Nuffield Dept Populat Hlth, Clin Trial Serv Unit, Oxford, England
[5] Univ Oxford, Nuffield Dept Populat Hlth, Epidemiol Studies Unit CTSU, Oxford, England
[6] Univ Otago, Dunedin Sch Med, Dunedin, New Zealand
来源：
NEPHROLOGY | 2018年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：25 / 25
页数：1
相关论文
共 50 条
  • [41] CHRONIC KIDNEY DISEASE IN HISPANICS: BASELINE CHARACTERISTICS OF THE HISPANIC CHRONIC RENAL INSUFFICIENCY COHORT (HCRIC) STUDY
    Fischer, Michael J.
    Ackerson, Lynn
    Cohan, Janet
    Feldman, Harold
    Go, Alan
    Lora, Claudia
    Mercado, Alejandro
    Ricardo, Ana
    Lash, James
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2010, 55 (04) : A54 - A54
  • [42] MEDICATION ADHERENCE IN ADULTS WITH ADVANCED CHRONIC KIDNEY DISEASE
    Tesfaye, W.
    Castelino, R. L.
    Wimmer, B. C.
    Mckercher, C.
    Jose, M. D.
    Peterson, G. M.
    Zaidi, S. T.
    NEPHROLOGY, 2018, 23 : 44 - 45
  • [43] Medication use among CKD patients: An analysis of baseline data from the CHOIR study
    Singh, AK
    Corwin, M
    Bhaduri, S
    Klausner, M
    Reddan, D
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2004, 43 (04) : A41 - A41
  • [44] Risk of chronic kidney disease in people living with HIV by tenofovir disoproxil fumarate (TDF) use and baseline D:A:D chronic kidney disease risk score
    Hsu, R.
    Brunet, L.
    Fusco, J.
    Beyer, A.
    Prajapati, G.
    Wyatt, C.
    Wohlfeiler, M.
    Fusco, G.
    HIV MEDICINE, 2021, 22 (05) : 325 - 333
  • [45] Cinacalcet use in pediatric chronic kidney disease A survey study
    Al-Ahmad, Rafif A.
    Sheerah, Areej A.
    Alhasan, Khalid A.
    Kari, Jameela A.
    SAUDI MEDICAL JOURNAL, 2020, 41 (05) : 479 - 484
  • [46] A STUDY OF ALLOPURINOL USE IN PATIENTS WITH GOUT AND CHRONIC KIDNEY DISEASE
    Sukhdeo, A.
    Sturgess, A.
    INTERNAL MEDICINE JOURNAL, 2014, 44 : 11 - 12
  • [47] Pooled Analysis of Tolerability With Fremanezumab Treatment in Patients With Episodic or Chronic Migraine and Cardiovascular Medication Use at Baseline
    Coppola, G.
    Cohen, J. M.
    Ning, X.
    Kessler, Y.
    Yang, R.
    Barbanti, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 156 - 156
  • [48] SELF-EFFICACY AND LONG-TERM MEDICATION USE IN PATIENTS WITH CHRONIC KIDNEY DISEASE
    Wierdsma, Judith
    van Zuilen, Arjan
    van der Bijl, Jaap
    JOURNAL OF RENAL CARE, 2011, 37 (03) : 158 - 166
  • [49] TRENDS IN ANTIDIABETIC MEDICATION USE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND CHRONIC KIDNEY DISEASE
    Gor, D.
    Touchette, D.
    VALUE IN HEALTH, 2016, 19 (03) : A210 - A210
  • [50] Assessing the impact of chronic kidney disease on individuals and populations: use of relative and absolute measures
    Roderick, Paul J.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 : 39 - 42
12345